News
Media
Medical World NewsPodcastsVideosInsightsPeer ExchangeMedia DayNews NetworkRoundtables
Conference
Conference CoverageConference Listing
Publication
More
CME/CE
Partners
Resources
Interactive ToolsSpecial ProjectsSponsored
Contribute
Case StudiesWriters and Mentors

Subscribe

  • News
  • Media
  • Conference
  • Publication
  • CME/CE
  • Partners
  • Resources
  • Contribute
  • Subscribe
  • Antimicrobial Stewardship
  • Blood-Borne Diseases
    • Ebola
    • HCV / Hepatitis
  • Coronavirus / COVID
  • Food Borne Infection / Food Safety
    • E. Coli
    • Food Safety
    • Listeria
    • Salmonella
  • Fungal Infections
    • Candida auris
  • Gastrointestinal Infections
    • C. Difficile
    • H. Pylori
    • Norovirus
  • Healthcare Associated Infections (HAI)
  • Prevention
    • Antibiotics
    • Immunizations
    • Vaccines
  • Respiratory Infections
    • Community-Acquired Pneumonia
    • Measles
    • Influenza
  • Sexually Transmitted Diseases
    • HIV / AIDS
    • HPV
    • HSV
    • PrEP
  • Skin & Soft Tissue Diseases
    • MRSA
  • Zoonotic & Vector-Borne Diseases
    • Lyme Disease
    • ZIKA
Spotlight -
Antimicrobial Stewardship|
Bench to Bedside With SIDP|
C. difficile |
Clinical Corner|
Fungal Infections|
Hepatitis|
RSV: A New Era in Prevention
Advertisement

Mikayla S. Johnson, PharmD; Renata O. Smith, PharmD, AAHIVP; and Melissa E. Badowski, PharmD, MPH, BCIDP, BCPS, AAHIVP

Advertisement

Articles by Mikayla S. Johnson, PharmD; Renata O. Smith, PharmD, AAHIVP; and Melissa E. Badowski, PharmD, MPH, BCIDP, BCPS, AAHIVP

The Preexposure Prophylaxis Pipeline

ByMikayla S. Johnson, PharmD; Renata O. Smith, PharmD, AAHIVP; and Melissa E. Badowski, PharmD, MPH, BCIDP, BCPS, AAHIVP
October 29th 2020
Advertisement

Latest Updated Articles



    Advertisement
    Advertisement

    Trending on Contagion Live

    1

    New Data Highlight Adult Pneumococcal Serotypes with Greater Antibiotic Resistance and Disease Burden Covered by Merck’s Vaccine

    2

    Developing a COVID-19 Vaccine Alternative

    3

    Oral Carbapenem Tebipenem HBr Demonstrates Non-Inferiority to IV Therapy in Phase III PIVOT-PO Trial

    4

    Introducing Cefiderocol Earlier in Difficult-to-Treat-Infections

    5

    Lori Handy, MD, MSCE, Discusses New Era of Dynamic, Trust-Based Health Communication

    • About Us
    • Advertise
    • Editorial
    • Contact Us
    • Do Not Sell My Information
    • Privacy
    • Terms & Conditions
    Contact Info

    259 Prospect Plains Rd, Bldg H
    Cranbury, NJ 08512

    609-716-7777

    Brand Logo

    © 2025 MJH Life Sciences®

    All rights reserved.

    Home
    About Us
    News
    Contact Us